We specialise in sourcing and distributing breakthrough, technology-rich products that support patients and healthcare professionals in addressing cardiovascular disease. The solutions we offer are carefully selected from leading global innovators and represent the latest in diagnostic, treatment, and disease management capabilities.
Each product is chosen for its clinical effectiveness, ease of use, and ability to make a meaningful difference in patient outcomes. By delivering access to these cutting-edge technologies, Hydrix Medical helps transform how cardiovascular care is delivered. Our goal is to improve quality of life for patients and support better-informed clinical decision-making.
Hydrix Medical Management
Vickie Edwards
Director of Sales & Operations
Vickie has more than 25 years’ of health technology industry expertise. She brings cardiothoracic clinical experience and a deep commercial capability and understanding of how to successfully bring new interventional cardiac devices to market. Her broad capabilities across sales, marketing, field operations, patient care and regulatory affairs further strengthen our senior leadership as we progress towards launch of a portfolio of cardiac products and technologies, initially in Asia-Pacific markets.
Mr Gavin Coote
Executive Chairman
Gavin is Executive Chairman of Hydrix Limited, an ASX-listed diversified Medtech company. Gavin’s 30 years Executive and Board leadership experience includes roles in financial advisory services, corporate mergers and acquisitions, early-stage venture investing, private equity turnarounds, and capital and debt raisings for listed and private companies. His experience is gained from a diverse range of industries and companies, with sizes from start-up through $1 billion revenues and includes 11 years in the USA. Companies include Hydrix Limited, Imperium Capital Group, Platinum Technology International and PwC. Gavin completed an MBA at the University of Michigan, a Bachelor of Economics at Monash University and is a member of the AICD.
Mr Paul Wright FAICD
Non-Executive Director
Paul has spent the last 18 years as CEO of three of Australia’s leading international technology and biomedical companies, specifically ASX listed Universal Biosensors (UBI), Invetech and Vision Biosystems. At universal Biosensors, Paul built long term partnerships with global diagnostics leaders Siemens Healthcare and Johnson & Johnson and led the company through a period of strong growth and new product development. Other past roles included 8 years with Bain & Company, and GM Corporate Development at TNT Logistics.
Ms Julie King
Non-Executive Director
Julie has more than 40 years’ experience in commercial and property negotiations, corporate communications, people and change management. She has held senior roles in maritime, airline, banking and FMCG industries. Julie is also a Director of a number of privately-owned businesses and the King Family Foundation.
Ms Alyn Tai
Corporate Counsel & Company Secretary
Alyn is a practising lawyer who specialises in the areas of corporate and commercial law, and the provision of company secretarial, corporate governance and legal counsel services to entities listed on the Australian Securities Exchange. Alyn holds a Bachelor of Laws from the University of Exeter, and was called to the Bar of England and Wales before being admitted to the Supreme Court of Victoria as an Australian lawyer.
Gareth Evans
Chief Financial Controller
Gareth has over 12 years’ experience as a finance professional across public practice and in the healthcare sector. He has extensive experience advising and developing finance teams in private and ASX listed companies, developing skills in strategic planning, people development and technical accounting, and finance matters. A member of the Institute of Chartered Accountants of England and Wales.
Alan Morris
Group Marketing Director
Alan has 28 years’ experience in new product development consulting, with expertise in disruptive innovation, new and emerging technologies, and driving marketing strategies for the MedTech and biomedical consulting markets. His experience includes marketing and development roles for more than 20 years with Invetech, a global leader in IVD and Cell Therapy product innovation.